{"doc_id": "PMC-1064873-16-Discussion-01.txt", "sent_id": "S1", "tokens": ["CD4", "+", "T", "cells", "orchestrate", "the", "Th1-type", "cell", "-", "mediated", "immune", "response", "in", "RA", "[", "22", "]", "."], "sentence": "CD4 + T cells orchestrate the Th1-type cell - mediated immune response in RA [ 22 ] .", "event_mentions": [], "entity_mentions": [{"id": "T1", "text": "CD4", "entity_type": "Protein", "start": 0, "end": 0}]}
{"doc_id": "PMC-1064873-16-Discussion-01.txt", "sent_id": "S2", "tokens": ["Activated", "CD4", "+", "T", "cells", "stimulate", "macrophages", ",", "synovial", "fibroblasts", ",", "B", "cells", ",", "and", "osteoclasts", "through", "the", "expression", "of", "cell", "surface", "molecules", "and", "Th1", "cytokines", ",", "thereby", "contributing", "to", "both", "the", "chronic", "inflammation", "and", "the", "joint", "destruction", "."], "sentence": "Activated CD4 + T cells stimulate macrophages , synovial fibroblasts , B cells , and osteoclasts through the expression of cell surface molecules and Th1 cytokines , thereby contributing to both the chronic inflammation and the joint destruction .", "event_mentions": [], "entity_mentions": [{"id": "T2", "text": "CD4", "entity_type": "Protein", "start": 1, "end": 1}]}
{"doc_id": "PMC-1064873-16-Discussion-01.txt", "sent_id": "S3", "tokens": ["CD4", "+", "T", "cells", "require", "two", "signals", "to", "be", "activated", ";", "antigen", "receptor", "occupancy", "and", "CD28", "-", "mediated", "costimulation", "."], "sentence": "CD4 + T cells require two signals to be activated ; antigen receptor occupancy and CD28 - mediated costimulation .", "event_mentions": [], "entity_mentions": [{"id": "T3", "text": "CD4", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T4", "text": "CD28", "entity_type": "Protein", "start": 15, "end": 15}]}
{"doc_id": "PMC-1064873-16-Discussion-01.txt", "sent_id": "S4", "tokens": ["In", "the", "ST", "lesion", ",", "the", "CD28", "ligands", ",", "both", "CD80", "and", "CD86", ",", "together", "with", "MHC", "class", "II", "antigens", ",", "are", "substantially", "expressed", "by", "antigen-presenting", "cells", "such", "as", "macrophages", "and", "dendritic", "cells", "[", "18-20", "]", "."], "sentence": "In the ST lesion , the CD28 ligands , both CD80 and CD86 , together with MHC class II antigens , are substantially expressed by antigen-presenting cells such as macrophages and dendritic cells [ 18-20 ] .", "event_mentions": [], "entity_mentions": [{"id": "T5", "text": "CD28", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T6", "text": "CD80", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T7", "text": "CD86", "entity_type": "Protein", "start": 12, "end": 12}]}
{"doc_id": "PMC-1064873-16-Discussion-01.txt", "sent_id": "S5", "tokens": ["The", "significance", "of", "CD28", "engagement", "in", "the", "T-cell", "-", "mediated", "disease", "process", "has", "recently", "been", "proven", "by", "the", "clinical", "efficacy", "of", "its", "blocker", "cytotoxic", "T-cell-associated", "antigen", "4", "(CD152)-IgG", "in", "RA", "patients", "[", "23", "]", "."], "sentence": "The significance of CD28 engagement in the T-cell - mediated disease process has recently been proven by the clinical efficacy of its blocker cytotoxic T-cell-associated antigen 4 (CD152)-IgG in RA patients [ 23 ] .", "event_mentions": [], "entity_mentions": [{"id": "T8", "text": "CD28", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T9", "text": "cytotoxic T-cell-associated antigen 4 (CD152)-IgG", "entity_type": "Protein", "start": 23, "end": 27}]}
{"doc_id": "PMC-1064873-16-Discussion-01.txt", "sent_id": "S6", "tokens": ["IL-10", "plays", "a", "predominant", "role", "in", "limiting", "immune", "and", "inflammatory", "responses", "by", "regulating", "the", "function", "of", "both", "macrophages", "and", "Th1", "cells", "[", "1", "]", "."], "sentence": "IL-10 plays a predominant role in limiting immune and inflammatory responses by regulating the function of both macrophages and Th1 cells [ 1 ] .", "event_mentions": [], "entity_mentions": [{"id": "T10", "text": "IL-10", "entity_type": "Protein", "start": 0, "end": 0}]}
{"doc_id": "PMC-1064873-16-Discussion-01.txt", "sent_id": "S7", "tokens": ["IL-10", "inhibits", "the", "tyrosine", "phosphorylation", "of", "the", "CD28", "molecule", "and", "the", "subsequent", "phosphatidylinositol", "3-kinase", "binding", "in", "T", "cells", ",", "and", "thereby", "directly", "acts", "on", "T", "cells", "[", "24", "]", "."], "sentence": "IL-10 inhibits the tyrosine phosphorylation of the CD28 molecule and the subsequent phosphatidylinositol 3-kinase binding in T cells , and thereby directly acts on T cells [ 24 ] .", "event_mentions": [], "entity_mentions": [{"id": "T11", "text": "IL-10", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T12", "text": "CD28", "entity_type": "Protein", "start": 7, "end": 7}]}
{"doc_id": "PMC-1064873-16-Discussion-01.txt", "sent_id": "S8", "tokens": ["In", "the", "present", "study", ",", "we", "found", "that", "PB", "CD4", "+", "T", "cells", "from", "patients", "with", "active", "RA", ",", "in", "the", "presence", "of", "IL-10", ",", "are", "able", "to", "produce", "higher", "levels", "of", "IFN-gamma", "after", "CD3", "and", "CD28", "costimulation", "than", "normal", "CD4", "+", "T", "cells", "."], "sentence": "In the present study , we found that PB CD4 + T cells from patients with active RA , in the presence of IL-10 , are able to produce higher levels of IFN-gamma after CD3 and CD28 costimulation than normal CD4 + T cells .", "event_mentions": [], "entity_mentions": [{"id": "T13", "text": "CD4", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T14", "text": "IL-10", "entity_type": "Protein", "start": 23, "end": 23}, {"id": "T15", "text": "IFN-gamma", "entity_type": "Protein", "start": 32, "end": 32}, {"id": "T16", "text": "CD28", "entity_type": "Protein", "start": 36, "end": 36}, {"id": "T17", "text": "CD4", "entity_type": "Protein", "start": 40, "end": 40}]}
{"doc_id": "PMC-1064873-16-Discussion-01.txt", "sent_id": "S9", "tokens": ["Despite", "high-level", "IL-10R1", "expression", "and", "constitutive", "STAT3", "activation", ",", "IL-10", "-", "induced", "tyrosine", "phosphorylation", "of", "STAT3", "is", "suppressed", "in", "RA", "CD4", "+", "T", "cells", ",", "in", "contrast", "to", "normal", "CD4", "+", "T", "cells", ",", "where", "STAT3", "phosphorylation", "is", "dose-dependently", "inducible", "by", "IL-10", "."], "sentence": "Despite high-level IL-10R1 expression and constitutive STAT3 activation , IL-10 - induced tyrosine phosphorylation of STAT3 is suppressed in RA CD4 + T cells , in contrast to normal CD4 + T cells , where STAT3 phosphorylation is dose-dependently inducible by IL-10 .", "event_mentions": [], "entity_mentions": [{"id": "T18", "text": "IL-10R1", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T19", "text": "STAT3", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T20", "text": "IL-10", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T21", "text": "STAT3", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T22", "text": "CD4", "entity_type": "Protein", "start": 20, "end": 20}, {"id": "T23", "text": "CD4", "entity_type": "Protein", "start": 29, "end": 29}, {"id": "T24", "text": "STAT3", "entity_type": "Protein", "start": 35, "end": 35}, {"id": "T25", "text": "IL-10", "entity_type": "Protein", "start": 41, "end": 41}]}
{"doc_id": "PMC-1064873-16-Discussion-01.txt", "sent_id": "S10", "tokens": ["Serum", "IL-6", "from", "RA", "patients", "induces", "STAT3", "but", "not", "STAT1", "phosphorylation", "in", "normal", "CD4", "+", "T", "cells", ",", "and", "exogenous", "IL-6", "induces", "the", "resistance", "to", "IL-10", "inhibition", "of", "IFN-gamma", "production", "."], "sentence": "Serum IL-6 from RA patients induces STAT3 but not STAT1 phosphorylation in normal CD4 + T cells , and exogenous IL-6 induces the resistance to IL-10 inhibition of IFN-gamma production .", "event_mentions": [], "entity_mentions": [{"id": "T26", "text": "IL-6", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T27", "text": "STAT3", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T28", "text": "STAT1", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T29", "text": "CD4", "entity_type": "Protein", "start": 13, "end": 13}, {"id": "T30", "text": "IL-6", "entity_type": "Protein", "start": 20, "end": 20}, {"id": "T31", "text": "IL-10", "entity_type": "Protein", "start": 25, "end": 25}, {"id": "T32", "text": "IFN-gamma", "entity_type": "Protein", "start": 28, "end": 28}]}
{"doc_id": "PMC-1064873-16-Discussion-01.txt", "sent_id": "S11", "tokens": ["RA", "CD4", "+", "T", "cells", "contain", "higher", "levels", "of", "SOCS1", "but", "contain", "lower", "levels", "of", "SOCS3", "transcripts", "in", "comparison", "with", "normal", "CD4", "+", "T", "cells", "."], "sentence": "RA CD4 + T cells contain higher levels of SOCS1 but contain lower levels of SOCS3 transcripts in comparison with normal CD4 + T cells .", "event_mentions": [], "entity_mentions": [{"id": "T33", "text": "CD4", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T34", "text": "SOCS1", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T35", "text": "SOCS3", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T36", "text": "CD4", "entity_type": "Protein", "start": 21, "end": 21}]}
{"doc_id": "PMC-1064873-16-Discussion-01.txt", "sent_id": "S12", "tokens": ["These", "findings", "indicate", "that", "CD4", "+", "T", "cells", "become", "resistant", "to", "the", "inhibitory", "effect", "of", "IL-10", "before", "migration", "into", "the", "inflamed", "ST", ",", "and", "suggest", "that", "this", "resistance", "may", "be", "attributable", "to", "impaired", "IL-10", "-", "dependent", "STAT3", "activation", ",", "in", "association", "with", "sustained", "STAT3", "phosphorylation", "and", "SOCS1", "induction", "."], "sentence": "These findings indicate that CD4 + T cells become resistant to the inhibitory effect of IL-10 before migration into the inflamed ST , and suggest that this resistance may be attributable to impaired IL-10 - dependent STAT3 activation , in association with sustained STAT3 phosphorylation and SOCS1 induction .", "event_mentions": [], "entity_mentions": [{"id": "T37", "text": "CD4", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T38", "text": "IL-10", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T39", "text": "IL-10", "entity_type": "Protein", "start": 33, "end": 33}, {"id": "T40", "text": "STAT3", "entity_type": "Protein", "start": 36, "end": 36}, {"id": "T41", "text": "STAT3", "entity_type": "Protein", "start": 43, "end": 43}, {"id": "T42", "text": "SOCS1", "entity_type": "Protein", "start": 46, "end": 46}]}
{"doc_id": "PMC-1064873-16-Discussion-01.txt", "sent_id": "S13", "tokens": ["IL-10", "-", "mediated", "inhibition", "of", "CD4", "+", "T-cell", "cytokine", "production", "is", "principally", "dependent", "on", "its", "inhibition", "of", "macrophage", "antigen-presenting", "cell", "function", "[", "1", "]", "."], "sentence": "IL-10 - mediated inhibition of CD4 + T-cell cytokine production is principally dependent on its inhibition of macrophage antigen-presenting cell function [ 1 ] .", "event_mentions": [], "entity_mentions": [{"id": "T43", "text": "IL-10", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T44", "text": "CD4", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T45", "text": "its", "entity_type": "Protein", "start": 14, "end": 14}]}
{"doc_id": "PMC-1064873-16-Discussion-01.txt", "sent_id": "S14", "tokens": ["However", ",", "this", "indirect", "inhibitory", "effect", "is", "thought", "to", "be", "restricted", "at", "the", "site", "of", "T-cell", "activation", "in", "RA", ",", "because", "macrophages", "in", "the", "ST", "express", "high", "levels", "of", "cytokines", ",", "CD80", "and", "CD86", "molecules", ",", "and", "MHC", "class", "II", "antigens", "[", "10", ",", "18-20", "]", "."], "sentence": "However , this indirect inhibitory effect is thought to be restricted at the site of T-cell activation in RA , because macrophages in the ST express high levels of cytokines , CD80 and CD86 molecules , and MHC class II antigens [ 10 , 18-20 ] .", "event_mentions": [], "entity_mentions": [{"id": "T46", "text": "CD80", "entity_type": "Protein", "start": 31, "end": 31}, {"id": "T47", "text": "CD86", "entity_type": "Protein", "start": 33, "end": 33}]}
{"doc_id": "PMC-1064873-16-Discussion-01.txt", "sent_id": "S15", "tokens": ["More", "recently", ",", "IL-10", "has", "been", "shown", "to", "induce", "the", "antigen", "-", "specific", "T-cell", "unresponsiveness", "by", "inhibiting", "CD28", "tyrosine", "phosphorylation", "[", "33", "]", "."], "sentence": "More recently , IL-10 has been shown to induce the antigen - specific T-cell unresponsiveness by inhibiting CD28 tyrosine phosphorylation [ 33 ] .", "event_mentions": [], "entity_mentions": [{"id": "T48", "text": "IL-10", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T49", "text": "CD28", "entity_type": "Protein", "start": 17, "end": 17}]}
{"doc_id": "PMC-1064873-16-Discussion-01.txt", "sent_id": "S16", "tokens": ["This", "direct", "effect", "also", "may", "be", "limited", "in", "active", "RA", "patients", ",", "because", "their", "PB", "CD4", "+", "T", "cells", "showed", "a", "defective", "IL-10", "inhibition", "of", "CD28", "-", "costimulated", "production", "of", "both", "IFN-gamma", "and", "IL-2", "."], "sentence": "This direct effect also may be limited in active RA patients , because their PB CD4 + T cells showed a defective IL-10 inhibition of CD28 - costimulated production of both IFN-gamma and IL-2 .", "event_mentions": [], "entity_mentions": [{"id": "T50", "text": "CD4", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T51", "text": "IL-10", "entity_type": "Protein", "start": 22, "end": 22}, {"id": "T52", "text": "CD28", "entity_type": "Protein", "start": 25, "end": 25}, {"id": "T53", "text": "IFN-gamma", "entity_type": "Protein", "start": 31, "end": 31}, {"id": "T54", "text": "IL-2", "entity_type": "Protein", "start": 33, "end": 33}]}
